Profound Medical (PROF) Change in Receivables (2024 - 2026)

Profound Medical's Change in Receivables history runs 3 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• On a quarterly basis, Change in Receivables rose 305.5% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 7046.94% increase from a year earlier, with the FY2025 full-year figure at $172000.0, up 192.47% from the prior year.
• Change in Receivables grew to $2.2 million in Q1 2026 per PROF's latest filing, from -$736000.0 in the prior quarter.
• Across five years, Change in Receivables topped out at $3.4 million in Q3 2025 and bottomed at -$1.4 million in Q2 2025.
• The 3-year median for Change in Receivables is -$297000.0 (2024), against an average of $247333.3.
• Biggest YoY gain for Change in Receivables was 1230.3% in 2025; the steepest drop was 261.59% in 2025.
• Year by year, Change in Receivables stood at $595000.0 in 2024, then slumped by 223.7% to -$736000.0 in 2025, then jumped by 404.35% to $2.2 million in 2026.
• Per Business Quant, the three latest PROF Change in Receivables figures stand at $2.2 million (Q1 2026), -$736000.0 (Q4 2025), and $3.4 million (Q3 2025).